| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.07 | 0.6 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.7 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |